Sequence-based typing of the HLA-A10/A19 group and confirmation of a pseudogene coamplified with A*3401
- PMID: 15935891
- DOI: 10.1016/j.humimm.2005.01.005
Sequence-based typing of the HLA-A10/A19 group and confirmation of a pseudogene coamplified with A*3401
Abstract
The strategy for sequencing human leukocyte antigen (HLA)-A was based on separate amplification of exons 2 and 3, followed by forward and reverse heterozygous sequencing of the alleles. Validation of the method was obtained by sequencing 11 individuals carrying alleles from all different HLA-A allele groups, except *43. All alleles could be correctly identified except A*3401. Unexpected polymorphic positions were identified in exon 3, even in individuals homozygous for A*3401. In addition, the pseudogene HLA-COQ or HLA-DEL linked to A*3401 was coamplified and sequenced. The problem was solved by using different amplification primers for exon 3 with mismatches for the two pseudogenes. A total of 252 unrelated individuals with at least one allele belonging to the A10 or A19 group were typed for HLA-A by this strategy. Ten different alleles were identified in the A10 group and 14 in the A19 group. As second allele a further 30 different subtypes from all different groups were sequenced. In 21 individuals, sequencing exon 1 was necessary to distinguish A*7401 from A*7402. The sequencing strategy, with separate amplification of the exons, has proven to be a robust method, resulting in reliable and efficient high-resolution HLA-A typing.
Similar articles
-
HLA-DQB1 sequencing-based typing updated.Tissue Antigens. 2007 Apr;69 Suppl 1:64-5. doi: 10.1111/j.1399-0039.2006.760_5.x. Tissue Antigens. 2007. PMID: 17445168
-
HLA-DQB1 sequencing-based typing using newly identified conserved nucleotide sequences in introns 1 and 2.Tissue Antigens. 2005 Aug;66(2):99-106. doi: 10.1111/j.1399-0039.2005.00445.x. Tissue Antigens. 2005. PMID: 16029429
-
HLA-DRB sequencing-based typing: an improved protocol which shows complete DRB exon 2 sequences and includes exon 3 of HLA-DRB4/5.Tissue Antigens. 2007 Apr;69 Suppl 1:61-3. doi: 10.1111/j.1399-0039.2006.760_4.x. Tissue Antigens. 2007. PMID: 17445167
-
Histocompatibility testing.Southeast Asian J Trop Med Public Health. 2002;33 Suppl 2:112-4. Southeast Asian J Trop Med Public Health. 2002. PMID: 12755280 Review.
-
Oligonucleotide arrays for high resolution HLA typing.Rev Immunogenet. 1999;1(2):220-30. Rev Immunogenet. 1999. PMID: 11253948 Review.
Cited by
-
Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).BMC Med Genet. 2006 Aug 3;7:69. doi: 10.1186/1471-2350-7-69. BMC Med Genet. 2006. PMID: 16887033 Free PMC article.
-
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.J Immunol. 2011 Feb 1;186(3):1575-88. doi: 10.4049/jimmunol.1002990. Epub 2011 Jan 5. J Immunol. 2011. PMID: 21209280 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials